Status:
RECRUITING
Posterior Reversible Encephalopathy Syndrome in the Critically Ill Patients
Lead Sponsor:
Ictal Group
Collaborating Sponsors:
Versailles Hospital
Conditions:
Posterior Reversible Encephalopathy Syndrome
Eligibility:
All Genders
18+ years
Brief Summary
Posterior Reversible Encephalopathy Syndrome prospective (PRES) registry. Data collection using a standardized form : demographic data and data related to the PRES, including circumstances of onset, d...
Eligibility Criteria
Inclusion
- age \>= 18 years
- Posterior Reversible Encephalopathy Syndrome defined as:
- combination of consciousness impairment, seizure activity, headaches, visual abnormalities, nausea/vomiting, and focal neurological signs AND
- cerebral imaging abnormalities involving the white matter (brain CT scan hypodensities AND/OR Brain MRI hypoT1, hyper T2 FLAIR)
- intensive care unit admission
Exclusion
- normal cerebral imaging
Key Trial Info
Start Date :
March 9 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2028
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT03470467
Start Date
March 9 2018
End Date
December 31 2028
Last Update
August 8 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Intensive Care Unit - Versailles Hospital
Le Chesnay, France, 78150